BioQuest Corp.
3700 Campus Drive, Suite 206
Newport Beach, CA 92660
Phone: (714) 978-4425
Celeste Murphy
Division of Corporation Finance
Office of Life Sciences
United States Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
Re: | BioQuest Corp. | |
Offering Statement on Form 1-A | ||
Filed: October 21, 2020 | ||
File No. 024-11151 |
November 24, 2020
Dear Ms. Murphy,
This letter sets forth the request of BioQuest Corp., (“BQST” or the “Company”) for Qualification of its Regulation A Offering.
Kindly be advised that BioQuest Corp. (the “Company”) requests that its Regulation A offering be qualified on Wednesday, November 25, 2020 at 3pm or as soon as practical thereafter.
In connection with the foregoing request, the Company hereby confirms and acknowledges that:
1. | should the Commission or the staff, acting pursuant to delegated authority, qualify the filing, it does not foreclose the Commission from taking any action with respect to the filing; | |
2. | the action of the Commission or the staff, acting pursuant to delegated authority, in qualifying the filing, does not relieve the Company from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and | |
3. | the Company may not assert staff comments and/or qualification as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States. |
We trust the foregoing is in order.
If you have any questions or require any additional information with respect to the above, please do not hesitate to contact me at (714) 978-4425 or Andrew Coldicutt of the Law Office of Andrew Coldicutt at (619) 228-4970. Thank you for your attention to this matter.
BioQuest Corp. | ||
/s/ Thomas Hemingway | ||
Name: | Thomas Hemingway | |
Title: | Chief Executive Officer, Director |